Studies on rodents and cells have been used to suggest that BPC-157 might help heal tissues like tendons, joints, nerves, the intestinal tract, stomach and skin, but these havent been supported by studies in humans
People with immune sensitivities or those in regulated sports (where BPC 157 use may be restricted) should be particularly careful
Your injection volumes are larger
Schedule your NAD+ consultation with Dr
(2023) found that GLP-1 receptor agonists reduced the risk of lower limb amputation by 43% compared to sulfonylureas (HR: 0.57, 95% CI: 0.390.84), with the greatest risk reduction observed in long-term users (HR: 0.44, 95% CI: 0.270.72).(26) However, GLP-1 receptor agonists did not significantly impact diabetic foot ulcer incidence (HR: 1.08, 95% CI: 0.871.35)
The peptides before and after results article discusses realistic timelines for seeing changes, and how long peptides take to work addresses the patience required